Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/605453


Zimmer Holdings, Inc. Product Pipeline Analysis


Description: Zimmer Holdings, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Zimmer Holdings, Inc.’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.

Reasons to buy

- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.


Contents: 1 3
1.1 List of Tables 9
1.2 List of Figures 10
2 Company Snapshot 11
2.1 Key Information 11
2.2 Company Overview 11
2.3 Financial Performance 11
2.4 Industry Outlook - Orthopedic Devices 11
2.5 Industry Outlook - Dental Devices 12
3 Business Description 13
3.1 Business Overview 13
3.2 Americas 13
3.2.1 Overview 13
3.2.2 Financials 13
3.2.3 Capital Expenditure 13
3.2.4 Key Strategies 13
3.3 Asia Pacific Segment 13
3.3.1 Overview 13
3.3.2 Financials 13
3.3.3 Capital Expenditure 14
3.3.4 Key Strategies 14
3.4 Europe Segment 14
3.4.1 Overview 14
3.4.2 Financials 14
3.4.3 Capital Expenditure 14
3.4.4 Key Strategies 14
3.5 Major Products and Services 14
3.5.1 Overview 14
4 History 17
5 Business Strategy 20
5.1 Mission Statement 20
5.2 Strategy 20
5.3 Corporate Social Responsibility 20
5.3.1 Overview 20
5.3.2 Specific CSR Initiatives 20
6 Value Chain Analysis 22
6.1 Manufacturing 22
6.1.1 In House Manufacturing 22
6.2 Product Development 23
6.2.1 Regulatory Approvals 23
6.2.2 Clinical Trials 23
6.2.3 Research and Development 23
6.3 Sales and Marketing 23
6.3.1 Partnerships and Alliances 23
6.3.2 Licensing Agreements 24
7 Competitors 25
8 Share Holding Structure 26
9 Key Employees 27
10 Key Employee Biographies 28
11 Company Statement 30
12 Locations And Subsidiaries 32
12.1 Head Office 32
12.2 Other Locations & Subsidiaries 32
13 Recent Developments 34
13.1 Strategy And Business Planning 34
13.1.1 Jul 21, 2008: Zimmer To Expand Its Indiana Operations 34
13.1.2 Feb 05, 2008: Zimmer To Expand Manufacturing Network In Ireland 34
13.1.3 May 04, 2007: Zimmer To Expand Manufacturing And Distribution Facilities 35
13.2 Financial Announcements 35
13.2.1 Jul 22, 2008: Zimmer Reports 2Q 2008 Results 35
13.2.2 Apr 24, 2008: Zimmer Reports Q1 2008 Results 36
13.2.3 Apr 03, 2008: Zimmer Takes Actions To Improve Quality Systems At Ohio Facility 37
13.2.4 Jan 29, 2008: Zimmer Declares Q4 2007 Results 37
13.2.5 Oct 24, 2007: Zimmer Declares Q3 2007 Results 38
13.2.6 Jul 25, 2007: Zimmer Declares Q2 2007 Results 38
13.2.7 Apr 25, 2007: Zimmer Reports Q1 2007 Results 39
13.2.8 Jan 29, 2007: Zimmer Reports Q4 2006 Results 40
13.2.9 Dec 12, 2006: Zimmer Announces Share Buyback Program 41
13.2.10 Oct 25, 2006: Zimmer Reports Q3 2006 Results 42
13.2.11 Jul 26, 2006: Zimmer Reports Q2 2006 Results 43
13.3 Corporate Communications 44
13.3.1 Aug 07, 2008: Zimmer Director Resigns 44
13.3.2 May 19, 2008: Zimmer Appoints Group President, Global Businesses 44
13.3.3 May 12, 2008: Zimmer Announces Management Changes 45
13.3.4 Mar 17, 2008: Zimmer Announces Board Changes 45
13.3.5 Nov 27, 2007: Zimmer Chairman To Resign, McGoldrick To Serve As Non-Executive Chairman 46
13.3.6 May 01, 2007: Zimmer Announces CEO And President 46
13.3.7 Feb 13, 2007: Zimmer Names Arthur Higgins To Board 46
13.3.8 Nov 20, 2006: Zimmer’s President And CEO Plans To Retire 46
13.4 Legal and Regulatory 46
13.4.1 Aug 05, 2008: Coughlin Stoia Files Class Action Suit Against Zimmer 46
13.4.2 Jul 24, 2008: Roy Jacobs Investigates Zimmer For Possible Securities Law And Other Violations 47
13.4.3 May 27, 2008: Class Action Law Suit Accuses Zimmer Of Kickbacks 47
13.4.4 Sep 27, 2007: Zimmer Settles Federal Investigation With US Attorneys 47
13.4.5 Jul 30, 2007: Biomet Announces Litigation Against Zimmer And Others 48
13.5 Product News 49
13.5.1 Jul 23, 2008: Zimmer Suspends Marketing Of Hip Replacement Product 49
13.5.2 Jul 14, 2008: Zimmer Holdings Issues Clarification Regarding NexGen Knee System 49
13.5.3 Feb 11, 2008: The New Joint In Town: Women No Longer Have Bones To Pick With Doctors Catering To Their Needs 49
13.5.4 Jan 08, 2008: Zimmer Spine Introduces New Rigid To Dynamic Stabilization Transition System First Procedures Completed In The United States 49
13.5.5 Dec 11, 2007: Zimmer Holdings Receives FDA Approval To Market Mobile Bearing Knee 50
13.5.6 Sep 04, 2007: Zimmer And Tutogen Announce Agreement For International Distribution Of Biological Products 50
13.5.7 May 16, 2007: Zimmer Holdings And Regeneration Technologies Enter Distribution Agreement For New Allograft Paste Implant 50
13.5.8 Apr 18, 2007: Zimmer Contour Ceramic Abutment Now Available 51
13.5.9 Feb 16, 2007: To Reverse or Not to Reverse: The Anatomical Shoulder System 51
13.5.10 Feb 14, 2007: Zimmer Holdings To Feature Innovative Gender Solutions Hip Replacement At 2007 AAOS Meeting 51
13.5.11 Feb 14, 2007: Zimmer Holdings To Feature Innovative Gender Solutions Hip Replacement At 2007 AAOS Meeting 52
13.5.12 Feb 14, 2007: Zimmer Theatre Opens with Shoulder Presentation 52
13.5.13 Feb 14, 2007: Zimmer To Profile Enhanced SmartTool Solutions At 2007 AAOS Meeting 52
13.5.14 Feb 09, 2007: Zimmer Holdings, Inc. Announces Agreement To Acquire Endius, Inc., A Leader in Minimally Invasive Spinal Surgery 53
13.5.15 Jan 01, 2007: Early Migration Pattern Of The Uncemented CLS Stem In Total Hip Arthroplasties 53
13.5.16 Oct 30, 2006: Zimmer Spine’s New Lumbar Plate System Allows For Greater Intraoperative Flexibility 53
13.5.17 Sep 25, 2006: First Dynesys Hydroxyapatite-Coated Screws From Zimmer Spine Implanted In The United States And Europe 54
13.5.18 Sep 14, 2006: Zimmer Holdings To Launch Innovative Locking Plate System At Orthopaedic Trauma Association Meeting 54
13.5.19 Jul 27, 2006: Zimmer One-Piece Implant Joins the Tapered Screw-Vent Implant System 55
13.5.20 Jul 06, 2006: Zimmer Holdings Receives US Regulatory Approval To Begin Sales Of Ceramic Hip Replacements 55
13.5.21 May 10, 2006: Gender Solutions High-Flex Knee Is The First Knee Replacement Shaped To Fit A Woman’s Anatomy 56
13.5.22 Apr 18, 2006: Zimmer Dental Introduces The Atlantis Abutment In Zirconia In The United States 56
13.5.23 Mar 22, 2006: Zimmer Holdings Acquires Intelligent Surgical Instrument Technology from MedTech S.A. 56
13.5.24 Dec 21, 2005: Zimmer Dental Announces Launch of the Hex Lock Contour Abutment 57
13.5.25 Oct 17, 2005: Zimmer Holdings And Heraeus Expand Agreement For Worldwide Distribution Of Bone Cement Products 57
13.5.26 Jul 27, 2005: Atlantis Abutments Now Compatible with SwissPlus 4.8 Implant Platforms 57
13.5.27 May 12, 2005: Locator Overdenture Attachment System Now Available from Zimmer Dental, Inc 58
13.5.28 Feb 03, 2005: Zimmer To Distribute Innovative Antibiotic Bone Cement 58
13.5.29 Jul 05, 2004: Zimmer Dental Announces the Availability of the 11.5mm-length Tapered Screw-Vent Implant 59
13.5.30 Jul 23, 2003: Zimmer Reports 19% Net Sales and 32% Diluted EPS Growth for Second Quarter 2003 59
13.5.31 Mar 11, 2003: Zimmer Launches Trilogy Acetabular System Constrained Liner In US 59
13.5.32 Apr 19, 2001: Sulzer Dental Introduces Puros Allograft Bone Graft Material 59
13.6 Product Approvals 60
13.6.1 Dec 11, 2007: Zimmer Holdings Receives FDA Approval To Market Mobile Bearing Knee 60
13.6.2 Jul 06, 2006: Zimmer Holdings Receives US Regulatory Approval To Begin Sales Of Ceramic Hip Replacements 60
13.6.3 May 10, 2006: Gender Solutions High-Flex Knee Is The First Knee Replacement Shaped To Fit A Woman’s Anatomy 60
13.7 Clinical Trials 61
13.7.1 Jan 01, 2007: Early Migration Pattern Of The Uncemented CLS Stem In Total Hip Arthroplasties 61
13.8 Other Significant Developments 61
13.8.1 Jun 19, 2008: Zimmer To Partner With AmeriCares For Global Product Donation Program 61
13.8.2 Jun 11, 2008: Zimmer To Present At William Blair Growth Stock Conference 62
13.8.3 Dec 13, 2006: Zimmer Issues 2007 Sales And Earnings Guidance 62
13.8.4 Nov 15, 2006: Zimmer To Support Board Declassification 62
13.8.5 Sep 18, 2006: Zimmer Amends By-Laws 62
13.8.6 Jun 13, 2006: Zimmer, Burrell To Develop Information Campaign 62
14 Zimmer Holdings, Inc. Pipeline Products 63
14.1 Zimmer Holdings, Inc. Product Pipeline Analysis 63
14.1.1 Zimmer Holdings, Inc. Pipeline Products By Equipment Type 63
14.1.2 Zimmer Holdings, Inc. Pipeline Products By Development Stage 64
14.1.3 Zimmer Holdings, Inc. Pipeline Products By Therapy Area 64
14.1.4 Zimmer Holdings, Inc. Pipeline Products By Clinical Trials 65
14.1.5 Zimmer Holdings, Inc. Pipeline Products By News Summary 65
14.2 Newcleus 65
14.2.1 Product Description 65
14.2.2 Product Status 65
14.3 Dynesys System 66
14.3.1 Product Description 66
14.3.2 Product Status 66
14.3.3 Clinical Trials 66
14.4 NexGen LPS-Flex Mobile Bearing and LPS-Mobile Bearing Knees 71
14.4.1 Product Description 71
14.4.2 Product Status 71
14.4.3 Clinical Trials 71
14.4.4 Product Milestone 72
15 Appendix 74
15.1 Methodology 74
15.1.1 Coverage 74
15.1.2 Secondary Research 75
15.1.3 Primary Research 75
15.1.4 Expert Panel Validation 76
15.2 Contact Us 76
15.3 About us76
15.4 Disclaimer 76


Companies Mentioned The following companies are the major competitors of Zimmer Holdings, Inc.: Biomet, Inc. Danaher Corporation DENTSPLY International Inc. DePuy, Inc. Medtronic, Inc. Nobel Biocare Holding AG Smith & Nephew Plc Straumann Holding AG Stryker Corporation Synthes GmbH Wright Medical Group, Inc. Young Innovations, Inc. 3M Company


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/605453

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 24/11/2009 20:28:42
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Zimmer Holdings, Inc. Product Pipeline Analysis
Web Address:
http://www.researchandmarkets.com/reports/605453
Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €504.00
Electronic (PDF) - Site License €1,007.00
Electronic (PDF) - Enterprisewide €1,511.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 24/11/2009 20:28:42

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)